Wanbury eyes contract research firms in US
Wanbury, the largest global manufacturer of diabetes management drug metformin, plans to acquire contract research and manufacturing services (CRAMS) companies in the US and Europe.
More: continued here
Wanbury, the largest global manufacturer of diabetes management drug metformin, plans to acquire contract research and manufacturing services (CRAMS) companies in the US and Europe.
More: continued here
Bank of India on Friday announced a consolidated net profit of Rs.19.59 billion ($489.96 million) during the fiscal year 2008.
More: continued here
Chief minister Vilasrao Deshmukh said on Thursday that the greenfield international airport at Navi Mumbai would be completed by 2012.
More: continued here
Private equity (PE) investors are now looking at investing only in residential projects priced between Rs 30 lakh and Rs 70 lakh.
More: continued here
Diversified agri-irrigation company Jain Irrigation will invest Rs 550 crore in Jalgaon district in Maharashtra in two projects under the state government’s mega projects policy.
More: continued here
Pharmaceutical companies will be able to produce life-saving proteins such as insulin, erythropoietin and interferon at one-eighth their current cost by using a process involving VFF2 technology.
More: continued here
Manipal Cure and Care (MCC), an initiative of the Manipal Education and Medical Group (MEMG), has launched Snorben, an anti-snoring nasal device, in India.
More: continued here
Exorbitant jet fuel and foreign exchange losses are likely to pull full service carrier Jet Airways into losses in the fourth quarter of 2007-08.
More: continued here
Inflation rose to near 44-month high of 7.83 per cent for the week ended May 3, against 7.61 per cent in the previous week
More: continued here
Fund houses have effected a sea change in their services since the Securities and Exchange Board of India (Sebi) waived the entry load for investors getting into mutual funds directly.
More: continued here